Unilateral government policy to promote cheaper drugs criticized

Published: 2002-04-16 06:59:00

Updated: 2002-04-16 06:59:00

The Korean Pharmaceutical Manufacturers Association (KPMA) says that the recently contemplating government policy to provide special incentives (guarantee of special margin towards hospitals) to the medical institutions in favor of low-priced drugs should be withdrawn, which may result in misuse/...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK